Pulmonary arterial hypertension (PAH) is a progressive, fatal disease, but prognosis improves with therapy. Unfortunately, diagnosis is often delayed because of the nonspecific symptoms of the disease. There are now several effective medications for treating this disease. Consensus evaluation and management guidelines are available and should be followed to optimize treatment of these patients.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Managed Care Medicine|
|State||Published - Nov 16 2012|
ASJC Scopus subject areas
- Health Policy